Savara Inc
NASDAQ:SVRA

Watchlist Manager
Savara Inc Logo
Savara Inc
NASDAQ:SVRA
Watchlist
Price: 2.78 USD 2.96%
Market Cap: 477.1m USD

P/S
Price to Sales

0
Current
0
Median
7.2
Industry
Higher than median
Lower than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
0
=
Market Cap
474.9m USD
/
Revenue
0 USD
Revenue Growth P/S to Growth
US
Savara Inc
NASDAQ:SVRA
Average P/S: 3 674 809.4
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
36 746 104.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.3
8%
0.8
US
Amgen Inc
NASDAQ:AMGN
4.9
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.8
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
11.6
10%
1.2
US
E
Epizyme Inc
F:EPE
1 917.2
N/A N/A
AU
CSL Ltd
ASX:CSL
5.1
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.9
7%
0.7
US
S
Seagen Inc
F:SGT
18.5
30%
0.6
NL
argenx SE
XBRU:ARGX
16.3
37%
0.4

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
N/A
2-Years Forward
P/S
N/A
3-Years Forward
P/S
9.2